Pharmaceutical Manufacturing Handbook: Production and

678 NASAL POWDER DRUG DELIVERY
72. Singla , A. K. , and Chawla , M. ( 2001 ), Chitosan: Some pharmaceutical and biological
aspects — An update , J. Pharm. Pharmacol. , 53 , 1047 – 1067 .
73. Illum , L. , Watts , P. , Fisher , A. N. , Hinchcliffe , M. , Norbury , H. , Jabbal - Gill , I. , Nankervis ,
R. , and Davis , S. S. ( 2002 ), Intranasal delivery of morphine , J. Pharm. Exp. Ther. , 301 ,
391 – 400 .
74. Illum , L. ( 2003 ), Nasal drug delivery — Possibilities, problems and solutions , J. Controlled
Release , 87 , 187 – 198 .
75. Illum , L. , Farraj , N. F. , and Davis , S. S. ( 1994 ), Chitosan as a novel nasal delivery system
for peptide drugs , Pharm. Res. , 8 , 1186 – 1189 .
76. Illum , L. , Jabbal - Gill , I. , Hinchcliffe , M. , Fisher , A. N. , and Davis , S. S. ( 2001 ), Chitosan
as a novel nasal delivery system for vaccines , Adv. Drug Deliv. Rev. , 51 , 81 – 96 .
77. Cheng , Y. - H. , Dyer , A. M. , Jabbal - Gill , I. , Hinchcliffe , M. , Nankervis , R. , Smith , A. , and
Watts , P. ( 2005 ), Intranasal delivery of recombinant human growth hormone (somatropin)
in sheep using chitosan - based powder formulations , Eur. J. Pharm. Sci. , 26 , 9 – 15 .
78. Thanou , M. M. , Verhoef , J. C. , Romeijn , S. G. , Nagelkerke , J. F. , Merkus , F. W. H. M. , and
Junginger , H. E. ( 1999 ), Effects of N - trimethyl chitosan chloride, a novel absorption
enhancer, on Caco - 2 intestinal epithelia and the ciliary beat frequency of chicken embryo
trachea , Int. J. Pharm. , 185 , 73 – 82 .
79. Kotze , A. F. , Lue ß en , H. L. , de Boer , A. G. , Verhoef , J. C. , and Junginger , H. E. ( 1998 ),
Chitosan for enhanced intestinal permeability: Prospects for derivatives soluble in
neutral and basic environments , Eur. J. Pharm. Sci. , 7 , 145 – 151 .
80. Bernkop - Schn ü rch , A. , Hornof , M. , and Guggi , D. ( 2004 ), Thiolated chitosans , Eur. J.
Pharm. Biopharm. , 57 , 9 – 17 .
81. Illum , L. , Jorgensen , H. , Bisgaard , H. , Krogsgaard , O. , and Rossing , N. ( 1987 ), Bioadhesive
microspheres as a potential nasal drug delivery system , Int. J. Pharm. , 39 , 189 – 199 .
82. Ugwoke , M. I. , Agu , R. U. , Jorissen , M. , Augustijns , P. , Sciot , R. , Verbeke , N. , and Kinget ,
R. ( 2000 ), Nasal toxicological investigations of Carbopol 971P formulation of apomorphine:
Effects on ciliary beat frequency of human nasal primary cell culture and in vivo
on rabbit nasal mucosa , Eur. J. Pharm. Sci. , 9 , 387 – 396 .
83. Soane , R. J. , Hinchcliffe , M. , Davis , S. S. , and Illum , L. ( 2001 ), Clearence characteristics
of chitosan based formulations in the sheep nasal cavity , Int. J. Pharm. , 217 , 183 – 191 .
84. Jones , N. ( 2001 ), The nose and paranasal sinuses physiology and anatomy , Adv. Drug
Deliv. Rev. , 51 , 5 – 19 .
85. Soane , R. J. , Frier , M. , Perkins , A. C. , Jones , N. S. , Davis , S. S. , and Illum , L. ( 1999 ), Evaluation
of the clearence characteristics of bioadhesive systems in humans , Int. J. Pharm. ,
178 , 55 – 65 .
86. Vivien , N. , Buri , P. , Balant , L. , and Lacroix , S. ( 1994 ), Nasal absorption of metoclopramide
administrated to man , Eur. J. Pharm. Biopharm. , 40 , 228 – 231 .
87. Holmberg , K. , Bj ö rk , E. , Bake , B. , and Edman , P. ( 1994 ), Infl uence of degradable starch
microspheres on human nasal mucosa , Rhinology , 32 , 74 – 77 .
88. Brime , B. , Ballesteros , M. P. , and Frutos , P. ( 2000 ), Preparation and in vitro characterization
of gelatin microspheres containing Levodopa for nasal administration , J. Microencapsul.
, 17 , 777 – 784 .
89. Preda , M. , and Leucuta , E. ( 2003 ), Oxprenolol - loaded bioadhesive microspheres: Preparation
and in vitro/in vivo characterization , J. Microencapsul. , 20 , 777 – 789 .
90. Kriwet , B. , and Kissel , T. ( 1996 ), Poly(acrylic acid) microparticles widen intercellular
spaces of Caco - 2 cell monolayers: An examination by confocal laser scanning microscopy
, Eur. J. Pharm. Biopharm. , 42 , 233 – 240 .